|Articles|September 28, 2012

U-Systems Seeks Partner as FDA Approves Breast Ultrasound

U-Systems Inc., the Silicon Valley maker of a cancer test for women with dense breasts, said it’s seeking to partner with a larger medical-imaging company after winning U.S. regulatory approval for the ultrasound technology.

A company with a women’s health unit would help Sunnyvale, California-based U-Systems and its 35 employees sell the somo-v ABUS breast-cancer ultrasound, Chief Executive Officer Ron Ho said in a telephone interview. The device, approved by the Food and Drug Administration last week, is the first ultrasound for the 40 percent of women who have thick connective and glandular breast tissue that normal mammograms can’t properly distinguish.

Read the full story: bloom.bg/UNufco

Source: Bloomberg

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo